May 10, 2023 / 05:40PM GMT
Joanna Sylvia Gajuk - BofA Securities, Research Division - VP
So welcome, everyone. Thanks for joining us for this session. So it's my pleasure to now host this discussion with Chemed. They are one of the largest hospice providers, but they also have another business, Roto-Rooter. Would try to hit on a little bit though this is a health care conference. But nevertheless, we have the entire team. So we have Kevin McNamara, we have Dave and Nick Westfall, the Head of the VITAS, the hospice business.
Questions and Answers:
Joanna Sylvia Gajuk - BofA Securities, Research Division - VPSo I'm going to go right into questions and start with VITAS since this is a health care conference. And obviously, the retention bonus program you guys implemented last year. It sounds like it's been going pretty well, some success there. So can you kind of flesh out, is there a way to quantify the benefit, how it's tracking versus your expectations? And also, I guess, to that end, are you seeing response in the market as in your competitors kind of trying to mimic what you're
Trustpilot
